Interestingly, serial sampling of blood in one patient and concomitant analysis of ctDNA showed that presence of KRAS mutation (p.G12D), not detected in the primary tumour, was found in both CTCs and ctDNA, whereas low frequency mutation in TP53 (p.P278R) was detected only in ctDNA. This evidence concerns the gene KRAS and neoplasm.